NFCR, Author at NFCR

NFCR

Make a Will Month

Did you know that August is “National Make a Will Month”? It’s the perfect time to be reminded of the importance of drafting or updating your will to ensure your final wishes are executed as you intended. Despite the importance of having a will, many Americans never get around to…...

Read more

In Remembrance of Dr. Zena Werb

The National Foundation for Cancer Research honors the life of Dr. Zena Werb, who passed on June 16th, 2020.  A world-renowned cell biologist, Dr. Werb was professor and vice-chair in the Department of Anatomy at the University of California, San Francisco (UCSF) and associate director for basic science at the…...

Read more

Meet Our Play4TheCure Summer 2020 Interns!

We are excited to introduce our Play4TheCure summer 2020 interns: Elizabeth Brustman and Grace Tiedge!...

Read more

DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Research to Support VAL-083’s Participation in a Pivotal Study for Glioblastoma Sponsored by the Global Coalition for Adaptive Research

SAN DIEGO, June 24, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today it has received a $500,000 loan from the National Brain Tumor Society (NBTS) and the National Foundation for Cancer…...

Read more

2020 and 2021 Szent-Györgyi Prize Invite

The 2020 and 2021 Szent-Györgyi Prize will both be awarded on April 24, 2021 The 2020 prize recipient is Susan Band Horwitz, Ph.D. for unlocking workings of cancer drugs of natural product origin. The 2021 prize recipient will be announced later this year. About the Prize: Every year, the Szent-Györgyi Prize…...

Read more

First-in-Class Drug Candidate Developed Through National Foundation for Cancer Research Funding Commences International Phase IIB Liver Cancer Clinical Trial

FOR IMMEDIATE RELEASE: May 19, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Three Decades of NFCR Basic and Translational Research Funding to Primary Investigator Dr. Yung-Chi Cheng and Project Advances New Systems Biology Paradigm for Cancer Treatment…...

Read more

NFCR Takes Steps to Address Cancer Community Needs During Coronavirus Pandemic

FOR IMMEDIATE RELEASE: April 14, 2020                                                  CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD –The National Foundation for Cancer Research (NFCR) has launched an online resource center targeted especially to cancer patients and caregivers during the COVID-19…...

Read more

Supporting the Women’s Venture Competition

The National Foundation for Cancer Research is honored to be an official partner for a highly unique investment event designed specifically to highlight, energize and fund promising cancer treatment technology companies led by female scientist-entrepreneurs. The AIM-HI Accelerator Fund’s Women’s Venture Competition, which will be held on May 20 at…...

Read more

NFCR-Backed Technology Receives FDA’s Assent for Lymphoma Clinical Trials

FOR IMMEDIATE RELEASE: March 12, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – A drug and drug delivery candidate technology, research into which has been funded by the National Foundation for Cancer Research (NFCR), has…...

Read more